login
login
Image header Agence Europe
Europe Daily Bulletin No. 12899
Contents Publication in full By article 26 / 36
SECTORAL POLICIES / Health

Covid-19, EMA recommends authorisation of Spikevax vaccine for children and Comirnaty booster dose for adolescents

The European Medicines Agency (EMA) gave the green light on Thursday 24 February to an extension of the use of Spikevax, the Covid-19 vaccine developed by the company Moderna, to children aged 6 to 11 years.

Spikevax already has a conditional marketing authorisation for use in people aged 12 and over. 

In this case, the EMA recommends intramuscular administration in the arm at four week intervals. The vaccine dose is 50 µg and provides an immune response in 6 to 11-year-olds comparable...

Contents

BEACONS
Russian invasion of Ukraine
SECURITY - DEFENCE
EXTERNAL ACTION
SECTORAL POLICIES
ECONOMY
INSTITUTIONAL
SOCIAL AFFAIRS
NEWS BRIEFS